Physician profile
Bradley Herrick
NPI 1700035235
$3,751.16
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,474 · 2020: $1,137 · 2021: $877 · 2022: $263.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $623.09 | 2019-2022 | |
| Leo Pharma INC. | $588.00 | 2019-2022 | |
| Pfizer INC. | $393.97 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $323.98 | 2019-2021 | |
| Ucb, INC. | $205.07 | 2019-2022 | |
| Galderma Laboratories, L.P. | $202.88 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $174.82 | 2020-2021 | |
| Genzyme Corporation | $168.12 | 2019-2021 | |
| Janssen Biotech, INC. | $158.87 | 2019-2022 | |
| Genentech USA, INC. | $146.51 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $114.75 | 2020 | |
| Dermira, INC. | $106.81 | 2019-2021 | |
| Epi Health, LLC | $91.52 | 2019-2022 | |
| Lilly USA, LLC | $78.66 | 2019-2021 | |
| Organogenesis INC. | $63.23 | 2020-2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $53.55 | 2020-2021 | |
| Amgen INC. | $49.53 | 2019 | |
| Prugen, INC. Pharmaceuticals | $38.77 | 2019 | |
| Nabriva Therapeutics, Plc | $34.57 | 2021-2022 | |
| Biofrontera INC. | $33.84 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.31 | 2019-2020 | |
| Dusa Pharmaceuticals, INC. | $23.81 | 2019 | |
| Merz North America, INC. | $21.25 | 2020 | |
| Allergan, INC. | $15.36 | 2019 | |
| Strata Skin Sciences, INC. | $10.89 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Herrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.